PS.
PublicSupply
account_balanceBuyersbusinessSuppliersdescriptionNotices
BuyersSuppliersNotices
verified_userData sourced from Contracts Finder, Find a Tender, and Companies House.
Contracts Finder ↗Find a Tender ↗Procurement Act 2023 ↗
  1. Home›
  2. Suppliers›
  3. Bristol Myers Squibb
BM

Bristol Myers Squibb

UK public-sector supplier
SME

Bristol Myers Squibb is a global biopharmaceutical company focused on discovering, developing, and delivering innovative medicines for patients with serious diseases.

bms.com ↗

Summary from the supplier’s website — unverified

Compare peers
Awarded
£45.6m
Live
13
Buyers
4
12m
—
At a glance
  • Quick answer
Profile
  • Social value
  • ESG & policies
  • Capabilities2
  • Buyer references
  • Accreditations
Track record · verified
  • KPI performance
  • Contracts13 / 20
  • Top buyers4
  • Category mix
  • Geography
  • Peers5
Trust & risk
  • Red flags0
  • Compliance
  • Modifications
  • News
Company
  • Companies House
  • Financial
  • Org tree
Quick answer — Bristol Myers SquibbUpdated 06 Jul 2026

At a glance · for buyers and watchdogs

Bristol Myers Squibb has won £45.6m across 4 public-sector buyers, with 13 live contracts.

Why: top buyer NHS England at 95% · 0 active risk flags · 0 modifications.

Decision signals
0Active red flags
No CH recordCompany status
13 of 20Live contracts
95%Top-buyer concentration
—Category exposure
0Contract modifications
If you're a buyer:CapabilitiesReferencesKPIComplianceWatchdog?FlagsModificationsConcentrationNews

Social value · 2/5

Commitments mapped to the Government Social Value Model themes. Each is tagged self-reported or from the website.

◐ From supplier website
JobsNo commitment stated✓
SkillsNo commitment stated✓
Environment1 commitment ↗✓Tackling inequality1 commitment ↗✓
CommunityNo commitment stated✓
Environment · 1
  • WebsiteBuilding a more resilient energy futureThe company is focused on supporting patients through sustainable energy initiatives.
Tackling inequality · 1
  • WebsiteBringing life-saving medicines to more patientsBristol Myers Squibb is committed to making its medicines accessible to low- and middle-income countries.

Extracted automatically from bms.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

ESG & policies vault · 0/5

Key governance & sustainability policies. Published documents link out; missing ones are greyed.

↔ Cross-checked
Net-zero planNot provided✓
Modern slavery statementNot provided✓
EDI policyNot provided✓
Anti-briberyNot provided✓
Data protectionNot provided✓

Capabilities

What this supplier does, where they sit, who they sell to.

◐ From website & notices
Services · 2
Research & DevelopmentConducting clinical trials and advancing medicines through innovative research. ↗MedicinesProviding a range of medicines across various therapeutic areas. ↗
Frameworks & DPS · 2 from notices
  • NHS Framework Agreement, Branded Medicines for London and South of EnglandNHS England · £13.3m
  • NHS Framework for the North of England, Branded MedicineNHS England · £7.7m

Extracted automatically from bms.com on Jul 2026. Not independently verified — treat as the supplier’s own marketing claims.

Case studies

Delivery stories the supplier has published, with sector and outcome.

⚑ Self-reported
—

No case studies yet

Once a claimed supplier publishes delivery stories — the buyer, the sector, what was delivered and the outcome — they appear here.

Buyer references

Named public-sector contacts who have agreed to act as a reference.

✓ Confirmed by buyer
—

No buyer references yet

Public-sector buyers can confirm they'll act as a reference for this supplier. Confirmed references — with the contract they relate to — show here.

Accreditations & memberships

Independently issued. Verification dates cross-checked against issuer registers.

↔ Cross-checked
—

No accreditations recorded

B-Corp, ISO, Cyber Essentials, Living Wage and similar credentials appear here once added by a claimed supplier and cross-checked against the issuing register.

KPI performance

Delivery, budget and satisfaction scores reported quarterly by buyers.

✓ Verified
84

No verified KPI scores yet

Once buyers report contract KPIs — delivery on time, on budget, satisfaction, adoption and accessibility — a weighted grade and breakdown appear here.

Contracts · 13 live · 7 historic

Pulled from Contracts Finder & Find a Tender. Most recent first.

✓ From notices
TitleBuyerCPVAwardedValueTermStatus
NHS National Generic Pharmaceuticals Wave 14a
NHS England3360000001 Feb 2023£2.1m2 yrsClosed
NHS Framework for the North of England, Branded Medicine
NHS England3360000001 Mar 2022£7.7m2 yrsClosed
NHS Framework for Midlands and East, Branded Medicines - Tranche A and Annual
NHS England3360000001 Mar 2022£7.0m2 yrsClosed
NHS Framework Agreement, Branded Medicines for London and South of England
NHS England3360000001 Sept 2021£13.3m2 yrsClosed
NHS Framework, North of England, Branded Medicines-Tranche A and Annual Tranche
NHS England3360000001 Mar 2021£7.3m2 yrsClosed
NHS Framework for the Midlands and East, Branded Medicines - Tranche B
NHS England3360000001 Mar 2021£6.2m2 yrsClosed
NHS Framework for the Midlands and East, Branded Medicines – Tranche B plus Cytokine Modulators and other Monoclonal Antibodies.
The NHS Commissioning Board (operating under the name of NHS England)33600000———Live
NHS Framework Agreement, Branded Medicines for London and South of England
NHS England33600000———Live
NHS National Generic Pharmaceuticals - Lenalidomide
NHS England33600000———Live
NHS Framework Agreement for the Supply of Direct Oral Anticoagulant (DOAC) Medicines for the NHS in England
The NHS Commissioning Board (operating under the name of NHS England)33690000———Live
Total live value — · mean award £2.3m1–10 of 20

Top buyers · 4 buyers · top 3 = 100%

Share of awarded value. Concentration fires above 40% for any single buyer.

✓ From notices
1
NHS England
11 contracts
95%
since 2021
2
Barts Health NHS Trust
1 contract
5%
3
The NHS Commissioning Board (operating under the name of NHS England)
5 contracts
0%
4
Northern Health and Social Care Trust NHSCT
3 contracts
0%

Geography

Distribution of awarded value by buyer region.

✓ From notices
UK · schematic only
Yorkshire11 contracts
95%
London1 contract
5%
North West5 contracts
0%
Northern Ireland3 contracts
0%

Peers

Suppliers with overlapping CPVs & buyers (last 24m). Bristol Myers Squibb highlighted.

✓ From notices
SupplierSME?Awarded · 24mContracts
DR
Dr Reddy's Laboratories (UK) Ltd
Yes£121.0m22
JA
Janssen-Cilag Ltd
Yes£117.6m18
AB
AbbVie Ltd
Yes£95.2m12
TA
Thornton and Ross Ltd
Yes£72.5m12
AC
ACCORD-UK LTD
Yes£71.2m21
BM
Bristol Myers Squibb
Yes——
Compare peers →

Red flags · 0 active

Automated scan of Companies House status, charges and insolvency records.

✓ Verified
No Companies House record linked — automated risk checks unavailable.

Compliance scorecard

Derived from Companies House filings — not a full supplier-assurance check.

↔ Cross-checked
No Companies House record linked — statutory compliance checks unavailable.

Modifications

Variations to awarded contracts logged under Procurement Act 2023 s.74.

✓ From notices
±

No modifications recorded

No published contract variations for this supplier. Modification notices appear here as they are issued under the Procurement Act 2023.

News mentions

UK trade press & nationals, matched to this supplier.

◰

No news mentions found

We haven't matched any recent UK press coverage to this supplier. Mentions appear here automatically as they're published.

Companies House

Registered details, directors and PSC.

✓ Live sync
🏛

No Companies House record linked

No Companies House number on file — this supplier may be overseas, a sole trader or a consortium.

Financial

Filed accounts from Companies House.

↔ From Cos House
£

No financial filings on record

Turnover, profit and headcount appear here once audited or micro-entity accounts are filed at Companies House.

Org tree

Group structure and ownership.

↔ From Cos House
—
— · this company

Independent. No parent company or subsidiaries recorded at Companies House for this entity.